A new study adds to the growing body of research linking inflammation to depression. Researchers found the molecule histamine directly inhibits the release of serotonin in the brain by attaching to inhibitory receptors on serotonin neurons in mice.
Neuroimaging study reveals three distinct response types in brain areas that control hunger, food intake, and appetite in patients who had undergone weight loss surgery.
Neuroimaging study revealed a significant number of professional rugby players had white matter abnormalities and abnormal changes to white matter volume over time.
Psilocybin, the psychoactive compound found in magic mushrooms, is as effective at treating depression as conventional SSRI antidepressants. Researchers report, that although not significantly significant, early findings reveal those treated with psilocybin experienced more rapid and greater reductions in depression symptoms than those treated with SSRIs.
Study sheds light on what causes normal proteins to convert to a diseased form associated with CJD and Kuru.
Researchers map how the structure of existing memories is reorganized in the brain as new experiences are committed to memory.
Researchers have identified a new condition associated with TBI in some patients. Vestibular agnosia, the newly identified disorder, worsens balance problems and reduces vertigo perception and dizziness.
Depression may be a new biomarker for the onset of specific bowel conditions, researchers report. The study found those with digestive disorders such as IBS, Crohn's disease, and ulcerative colitis were more likely to be diagnosed with depression up to nine years prior to being diagnosed with bowel conditions.